These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11814184)

  • 1. The potential of 19F NMR spectroscopy for rapid screening of cell cultures for models of mammalian drug metabolism.
    Corcoran O; Lindon JC; Hall R; Ismail IM; Nicholson JK
    Analyst; 2001 Dec; 126(12):2103-6. PubMed ID: 11814184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorine-19 NMR chemical shift probes molecular binding to lipid membranes.
    Chekmenev EY; Chow SK; Tofan D; Weitekamp DP; Ross BD; Bhattacharya P
    J Phys Chem B; 2008 May; 112(20):6285-7. PubMed ID: 18422359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 19F and 1H magnetic resonance strategies for metabolic studies on fluorinated xenobiotics: application to flurbiprofen [2-(2-fluoro-4-biphenylyl)propionic acid].
    Wade KE; Wilson ID; Troke JA; Nicholson JK
    J Pharm Biomed Anal; 1990; 8(5):401-10. PubMed ID: 2081200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs.
    Martino R; Gilard V; Desmoulin F; Malet-Martino M
    J Pharm Biomed Anal; 2005 Aug; 38(5):871-91. PubMed ID: 16087049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternate strategies to obtain mass balance without the use of radiolabeled compounds: application of quantitative fluorine (19F) nuclear magnetic resonance (NMR) spectroscopy in metabolism studies.
    Mutlib A; Espina R; Atherton J; Wang J; Talaat R; Scatina J; Chandrasekaran A
    Chem Res Toxicol; 2012 Mar; 25(3):572-83. PubMed ID: 22292524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugs.
    Martino R; Malet-Martino M; Gilard V
    Curr Drug Metab; 2000 Nov; 1(3):271-303. PubMed ID: 11465049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of site-specific binding and co-binding of ligands to macromolecules using 19F NMR.
    Jenkins BG
    Life Sci; 1991; 48(13):1227-40. PubMed ID: 2002752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated metabolite identification by "extraction-NMR".
    Gerhard U; Thomas S; Mortishire-Smith R
    J Pharm Biomed Anal; 2003 Jul; 32(3):531-8. PubMed ID: 14565558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products.
    Silva Elipe MV; Li L; Nagapudi K; Kook AM; Cobas C; Iglesias I; Peng C
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28872126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of (19)  F time-domain NMR to measure content in fluorine-containing drug products.
    Silva Elipe MV; Li L; Nagapudi K; Kook AM; Cobas C; Iglesias I; Peng C
    Magn Reson Chem; 2016 Jun; 54(6):531-8. PubMed ID: 25773191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of fluorophenyl pyridine carboxylic acids by the model fungus Cunninghamella elegans.
    Palmer-Brown W; Dunne B; Ortin Y; Fox MA; Sandford G; Murphy CD
    Xenobiotica; 2017 Sep; 47(9):763-770. PubMed ID: 27541932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 19F nuclear magnetic resonance as a tool to investigate microbial degradation of fluorophenols to fluorocatechols and fluoromuconates.
    Boersma MG; Dinarieva TY; Middelhoven WJ; van Berkel WJ; Doran J; Vervoort J; Rietjens IM
    Appl Environ Microbiol; 1998 Apr; 64(4):1256-63. PubMed ID: 9546160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heteronuclear 19F-1H statistical total correlation spectroscopy as a tool in drug metabolism: study of flucloxacillin biotransformation.
    Keun HC; Athersuch TJ; Beckonert O; Wang Y; Saric J; Shockcor JP; Lindon JC; Wilson ID; Holmes E; Nicholson JK
    Anal Chem; 2008 Feb; 80(4):1073-9. PubMed ID: 18211034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of 19F nuclear magnetic resonance to investigate microbial biotransformations of organofluorine compounds.
    Murphy CD
    OMICS; 2007; 11(3):314-24. PubMed ID: 17883342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance spectroscopy: a powerful tool for drug metabolism studies.
    Malet-Martino MC; Martino R
    Biochimie; 1992; 74(9-10):785-800. PubMed ID: 1467338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by [19F]-nuclear magnetic resonance spectroscopy in vivo.
    Port R; Hanisch F; Becker M; Bachert P; Zeller J
    Cancer Chemother Pharmacol; 1999; 44(1):65-73. PubMed ID: 10367751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coupling of HPLC with 19F- and 1H-NMR spectroscopy to investigate the human urinary excretion of flurbiprofen metabolites.
    Spraul M; Hofmann M; Wilson ID; Lenz E; Nicholson JK; Lindon JC
    J Pharm Biomed Anal; 1993 Oct; 11(10):1009-15. PubMed ID: 8305581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorine nuclear magnetic resonance spectroscopy of human biofluids in the field of metabolic studies of anticancer and antifungal fluoropyrimidine drugs.
    Malet-Martino M; Gilard V; Desmoulin F; Martino R
    Clin Chim Acta; 2006 Apr; 366(1-2):61-73. PubMed ID: 16337167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the metabolism of fluorinated xenobiotics in the rat using 19F-NMR and 1H-NMR spectroscopy.
    Ghauri FY; Blackledge CA; Wilson ID; Nicholson JK
    J Pharm Biomed Anal; 1990; 8(8-12):939-44. PubMed ID: 2100646
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.